LBA Wealth Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,000
Closed -$15K 488
2016
Q2
$15K Buy
+1,000
New +$12.8K 0.01% 279

LBA Wealth Management's SGNT Position: Q3 2016 in Review

LBA Wealth Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 1,000 shares — an estimated $15K sold.

LBA Wealth Management first reported a position in SGNT in Q2 2016 and held it in 1 quarter. The position peaked at $15K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • LBA Wealth Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • LBA Wealth Management sold 1,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $15K.
  • LBA Wealth Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2016 and held it in 1 quarter.
  • LBA Wealth Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $15K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on LBA Wealth Management's 13F filing for Q3 2016, filed 10 Nov 2016.